One-Year-Old infant breaks record with successful robotic surgery using SSI Mantra

Written by Arushi Sharma

In a groundbreaking medical feat, a one-year-old from Bidar, Karnataka, underwent robotic surgery, setting a new milestone in Indian healthcare.

One-Year-Old infant breaks record with successful robotic surgery using SSI Mantra
A one-year-old from Bidar, Karnataka, undergoes groundbreaking robotic surgery, marking a milestone in Indian medical history.

A one-year-old child from Bidar, Karnataka, has made medical history in India by becoming the youngest individual to undergo a robotic surgery. Dr. Chandra Mohan Vaddi, a urologist at Preeti Urology & Kidney Hospitals, Hyderabad, performed a pyeloplasty on the infant utilizing the SSI Mantra, a revolutionary Made in India surgical robot.

The infant was diagnosed with a blocked ureteropelvic junction, a condition hindering the normal flow of urine from the kidney. While open surgery and laparoscopy were traditional options, Dr. Vaddi opted for robotic surgery due to its advanced features, including magnified 3D vision, precise instruments, and enhanced access to the surgical site.

"This successful surgery signifies a landmark moment in Indian medical history," remarked Dr. Vaddi. "It showcases the potential of Indian innovation to revolutionize surgery, making it safer, more precise, and cost-effective."
Dr. Sudhir Prem Srivastava, the founder of SSI Innovations and the mastermind behind the SSI Mantra system, commended the medical team's achievement. He expressed confidence that the SSI Mantra system will democratize robotic surgery, making it accessible to a broader segment of the Indian population.

The SSI Mantra system, the first of its kind designed and manufactured in India, offers cost-effective solutions and supports a wide array of surgeries, including cardiac procedures. With regulatory approvals secured in India, Indonesia, and Guatemala, the system has already been utilized in over 1,000 surgeries spanning 50 different procedures. SS Innovations is actively pursuing regulatory clearances in the United States and Europe to expand its global footprint.

Following the successful pyeloplasty procedure, the infant is recovering well and is expected to be discharged soon, marking a triumph for medical innovation and paving the way for future advancements in pediatric surgery.

Share article